Diperoxochloric acid - DermaTools

Drug Profile

Diperoxochloric acid - DermaTools

Alternative Names: CL05; DermaPro® (CL05); Woxheal

Latest Information Update: 10 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator DermaTools
  • Developer Centaur Pharmaceuticals
  • Class Antiulcers; Disinfectants; Small molecules
  • Mechanism of Action Cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Diabetic foot ulcer
  • Phase II/III Leg ulcer
  • Discontinued Burns

Most Recent Events

  • 09 Aug 2017 CytoTools plans a phase II/III trial for Venous leg ulcer in Europe (Intralesional) (CytoTools pipeline, August 2017)
  • 09 Aug 2017 CytoTools plans a phase III trial for Diabetic foot ulcer in Europe (Intralesional) (CytoTools pipeline, August 2017)
  • 07 Aug 2017 Phase-III development for Diabetic foot ulcer is ongoing in Europe (Intralesional) (CytoTools pipeline, August 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top